DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 52 · February 2019 DOI: 10.1055/s-009-42493

Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
Abstracts of the 1st Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
Seminaris Campus Hotel Berlin, Germany, 06.–08.03.2019

Editors: Manfred Gerlach, Würzburg; Jürgen Deckert, Würzburg; Sabine Herpertz, Heidelberg; Jens Wiltfang, Göttingen

P3.1
Maul, S; Endlich, L; Hartmann, A; Konte, B; Krause, M; Giegling, I; Rujescu, D: Association of single-nucleotide polymorphisms implicated in Alzheimer's disease with cognitive phenotypes
P3.2
Hartmann, A; Plagg, B; Konte, B; Giegling, I; Stamm, S; Rujescu, D: Influence of RNA-binding proteins on Alzheimer's disease and related cognitive endophenotypes
P3.5
Faltraco, F; Palm, D; Uzoni, A; Rook, H; Thome, J: Body mass index and clock gene expression in human dermal fibroblasts
P3.7
Pfeifer, J; Jung, M; Jung, J; Carla, H; Toni, E; Giegling, I; Navarrete Santos, A; Rujescu, D: Analysing aged neural stem cells and the impact of different apolipoprotein E genotypes
P3.10
Jung, M; Majer, A; Reinsch, J; Schiller, J; Puls, A; Flegel, N; Ehrhardt, T; Fuszard, M; Hartmann, A; Konte, B; Rujescu, D: Analysing schizophrenia risk variants in neurexin 1 using functional and mature neuronal cultures from patient-derived induced pluripotent stem cells